Articles by Jill Wechsler - Pharmaceutical Executive


Articles by Jill Wechsler

Wrangling Over Research Results

May 21, 2009

Marketers fear a Catch-22 if they have to write research summaries that FDA considers illegal promotion.

Compared to What?

May 1, 2009

Pharma fears comparative effectiveness research will focus on costs and stymie personalized medicine.

Kickoff for Reform

Apr 1, 2009

In addition to overhauling healthcare, Congress is weighing proposals for updating FDA policies and expanding access to drugs.

Through the Looking Glass

Mar 1, 2009

The latest buzzword in pharma is "transparency"

Securing Savings

Feb 1, 2009

A close look at the healthcare industry will separate real cost-cutting measures from money-saving myths.

FDA Turnaround Time

Jan 1, 2009

Will more resourches and new leadership fix FDA, or is a major overhaul in order?

Challenge and Challenges

Dec 1, 2008

To expand health coverage amid an economic crisis, Obama will be looking hard for ways to cut costs

Resolving Conflicting Interests

Financial links to biomedical researchers may lead to stiffer disclosure rules for pharma and challenges for research partnerships
Nov 1, 2008

As Congress moves to curb industry influence, support for med ed is waning

Part D Under Attack

Oct 1, 2008

Congressional leaders ready campaign to curb Medicare drug plans.


Click here